Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Nova Eye Medical Ltd
EYENova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter which offers malleability and manoeuvrability than common nylon alternatives; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia. Address: 107 Rundle Street, Kent Town, SA, Australia, 5067
Analytics
Objectif de Cours de WallStreet
1.08 AUDRatio C/B
–Rendement du dividende
–Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés EYE
Analyse des dividendes EYE
Croissance des dividendes sur 5 ans
–Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
-403 %Historique des dividendes EYE
Valorisation des titres EYE
financières EYE
Résultats | 2019 | Dynamique |